RINGAFEMA vaginal delivery system 0.12 mg/24 h+0.015 mg/24 h
Nombre local: RINGAFEMA Système de diffusion vaginal 0.12 mg/24 h+0.015 mg/24 hPaís: Luxemburgo
Laboratorio: Mylan Pharmaceuticals Inc.
Vía: Vía vaginal
Forma: Sistema de liberacíon vaginal
ATC: Vaginal ring with progestogen and estrogen (G02BB01)
Seleccionar país:
11 equivalencias en Alemania
-
CIRCLET vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal -
CYCLELLE vaginal delivery system 120 µg/24 h+15 µg/24 hSistema de liberacíon vaginalVía vaginal
-
GINORING vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal
-
NUVARING AXICORP vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal
-
NUVARING EMRA vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal
-
NUVARING EURIM vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal
-
NUVARING EUROPEAN vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal
-
NUVARING HAEMATO-PHARM vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal
-
NUVARING KOHLPHARMA vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal
-
NUVARING vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal
-
VERI-ARISTO vaginal delivery system 0.120 mg/24 h+0.015 mg/24 hSistema de liberacíon vaginalVía vaginal
